Clinical Trials · NCT06497049
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Geropharm
- Enrollment
- 120
- Start date
- Jun 2023
- Locations
- 1 site, Russia
- Primary endpoint
- AUC 0-t